Use of progestational agents in the management of endometrial cancer
- 1 December 1965
- Vol. 18 (12), 1563-1579
- https://doi.org/10.1002/1097-0142(196512)18:12<1563::aid-cncr2820181208>3.0.co;2-p
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Management of advanced endometrial adenocarcinoma with medroxyprogesterone acetateAmerican Journal of Obstetrics and Gynecology, 1965
- Histological effects of progestins on hyperplasia and carcinoma in situ of the endometrium—Further observationsMetabolism, 1965
- Effect of a Progestational Agent on Endometrial Hyperplasia and Endometrial CancerObstetrics & Gynecology, 1964
- The teaching hospital experienceAmerican Journal of Obstetrics and Gynecology, 1963
- A Progestogen for Treatment of Advanced Endometrial CancerJAMA, 1963
- TREATMENT OF CARCINOMA IN SITU OF THE ENDOMETRIUMClinical Obstetrics and Gynecology, 1962
- CLINICAL AND HISTOPATHOLOGIC EVALUATION OF EFFECT OF 17-ALPHA-HYDROXYPROGESTERONE-17-CAPROATE ON ENDOMETRIAL CARCINOMA1961
- Histological effects of progestins on hyperplasia and carcinoma in situ of the endometriumCancer, 1959
- An endocrine basis for endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1959
- Genesis of endometrial carcinoma.I. Study of Prior BiopsiesCancer, 1949